1-4 of 4
Lingfei Xu
Close
Sort by
Journal Articles

Neonatal Gene Transfer Induces Tolerance to Human Factor VIII in Mice and Cats.

Lingfei Xu, MD, Manxue Mei, MS, Mark E. Haskins, VMD, PhD, Karyn Cullen, Katherine P. Ponder, MD
Journal: Blood
Blood (2005) 106 (11): 215.
https://doi.org/10.1182/blood.V106.11.215.215
Published: 2005
Journal Articles

DDAVP-Induced Increase of Factor VIII Activity in Blood Is Likely Due To Release of Factor VIII That Is Synthesized by Endothelial Cells.

Lingfei Xu, MD, Timothy C. Nichols, MD, Stephanie McCorquodale, Aaron Dillow, Elizabeth Merricks, Katherine P. Ponder, MD
Journal: Blood
Blood (2004) 104 (11): 692.
https://doi.org/10.1182/blood.V104.11.692.692
Published: 2004
Journal Articles

Neonatal gene transfer with a retroviral vector results in tolerance to human factor IX in mice and dogs

Jun Zhang, Lingfei Xu, Mark E. Haskins, Katherine Parker Ponder
Journal: Blood
Blood (2004) 103 (1): 143–151.
https://doi.org/10.1182/blood-2003-06-2181
Published: 2004
Journal Articles

Neonatal or hepatocyte growth factor–potentiated adult gene therapy with a retroviral vector results in therapeutic levels of canine factor IX for hemophilia B

Lingfei Xu, Cuihua Gao, Mark S. Sands, Shi-Rong Cai, Timothy C. Nichols, Dwight A. Bellinger, Robin A. Raymer, Stephanie McCorquodale, Katherine Parker Ponder
Journal: Blood
Blood (2003) 101 (10): 3924–3932.
https://doi.org/10.1182/blood-2002-10-3050
Published: 2003